देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
Diclofenac sodium
Haleon Ireland Limited
D11AX; M02AA15
Diclofenac sodium
1 percent weight/weight
Gel
Product not subject to medical prescription
Other dermatologicals; diclofenac
Marketed
2003-10-17
PACKAGE LEAFLET: INFORMATION FOR THE USER VOLTAROL EMULGEL 1% W/W GEL diclofenac diethylammonium 1.16% w/w corresponding to diclofenac sodium 1% w/w For joint, back and muscular pain relief Relieves pain, reduces inflammation, cooling effect READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. However, you still need to use Voltarol Emulgel 1% w/w Gel carefully to get the best results from it. • Keep this leaflet. You may need to read it again. Note that this leaflet is revised on a regular basis with the latest information on your medicine. Please refer to the date at the end of this leaflet. • Ask your pharmacist if you need more information or advice. • You must contact a doctor if your symptoms worsen or do not improve within 7 days. • If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist. WHAT IS IN THIS LEAFLET 1. What Voltarol Emulgel 1% w/w Gel is and what it is used for 2. What you need to know before you use Voltarol Emulgel 1% w/w Gel 3. How to use Voltarol Emulgel 1% w/w Gel 4. Possible side effects 5. How to store Voltarol Emulgel 1% w/w Gel 6. Contents of the pack and other information 1.WHAT VOLTAROL EMULGEL 1% W/W GEL IS AND WHAT IT IS USED FOR Voltarol Emulgel 1% w/w Gel contains the active ingredient diclofenac which is from the group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). Voltarol Emulgel 1% w/w Gel is used in adults, the elderly and adolescents aged 14 years and over to relieve pain and reduce swelling in a number of painful conditions affecting the joints and muscles, e.g. sprains, strains and bruises. It is also used to relieve the pain of muscular rheumatism. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE VOLTAROL EMULGEL 1% W/W GEL DO NOT USE VOLTAROL EMULGEL 1% W/W GEL IF YOU: • are allergic (hypersensitive) to diclofenac, propylene glycol, benzyl benzoate, isopropyl alcohol or any of the oth पूरा दस्तावेज़ पढ़ें
Health Products Regulatory Authority 05 July 2023 CRN00DPJ2 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Voltarol Emulgel 1% w/w Gel 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Voltarol Emulgel contains diclofenac diethylammonium 1.16% w/w corresponding to diclofenac sodium 1% w/w. Excipients with known effect: Contains propylene glycol (5% w/w) and benzyl benzoate (0.003% w/w) For a full list of excipients, see Section 6.1. 3 PHARMACEUTICAL FORM Gel. Voltarol Emulgel is a white, pleasantly perfumed, homogeneous, non-greasy emulsion in an aqueous gel. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS In adults, the elderly and adolescents aged 14 years and over for the local symptomatic relief of pain and inflammation in: -trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises. -localised forms of soft tissue rheumatism. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For cutaneous use only. _Adults _ _and children aged 14 years and over: _ Voltarol Emulgel should be rubbed gently into the skin. Depending on the size of the affected site to be treated 2-4g (a circular shaped mass approximately 2.0-2.5cm in diameter) should be applied 3-4 times daily. After application, the hands should be washed unless they are the site being treated. If the condition does not improve or worsens within 7 days of starting treatment, patient should consult their doctor to exclude an alternative underlying cause of pain. _Use in the elderly: _The usual adult dose may be used. _Children and adolescents below 14 years _: There are insufficient data on efficacy and safety available for children and adolescents below 14 years of age (see also contraindications section 4.3). 4.3 CONTRAINDICATIONS Patients with or without chronic asthma in whom asthma, angioedema, urticaria or acute rhinitis are precipitated by aspirin or other non-steroidal anti-inflammatory agents. During the last trimester of pregnancy. Hypersensitivity to diclofenac, aspirin or other non-steroidal ant पूरा दस्तावेज़ पढ़ें